Asante Capital congratulates partner Mill Point Capital on the closing oversubscribed at USD 1.7 billion
We are pleased to share that our client, Mill Point Capital has closed its latest fund; Mill Point Capital Partners III, L.P. (“Fund III”), oversubscribed at USD 1.7 billion.
Asante Capital congratulates partner Longreach for JPY 78 billion close of LCP4
We are pleased to share that our client, Longreach, has closed its latest fund, Longreach Capital Partners IV (LCP4), at JPY 78 billion.
Asante Capital Congratulates Partner GRO for EUR 150 million Close of Generation I
Backed by existing investors along with new partners, the launch elevates GRO’s total assets under management to EUR 1.2 billion.
Asante Capital Celebrates Partner Tenzing for the GBP 900 million Close of Tenzing III
We are delighted to announce that Tenzing has closed its third fund, Tenzing III, with total commitments exceeding GBP 900 million, reaching its hard cap with excess demand.
Asante Capital congratulates its partner eevolve on the final close of their first fund at the EUR 372 million hard cap
Asante Capital Group acted as eevolve’s exclusive global fundraising adviser, with Clifford Chance acting as fund legal adviser.
Asante Capital congratulates its partner Headway Capital Partners for closing its fifth fund over target
We are pleased to share that Headway Capital Partners has closed its fifth fund, HIP V, at EUR 627 million, exceeding its EUR 500 million target.
Asante Capital congratulates Maguar Capital on the successful closing of Fund 2 at a hard cap of EUR 306 million
We are pleased to share that Maguar, a Munich-based investor group focused on B2B software companies in the DACH region, has closed Maguar 2 at EUR 306 million, significantly exceeding the EUR 250 million target.
Asante Capital congratulates partner HighLight Capital (HLC) on the final closing of its flagship HLC USD Fund IV at US$550 million
We are delighted to share that HighLight Capital (HLC), a private equity firm focusing on venture and growth investments across healthcare and consumer health sectors in China, held the final close of its flagship HLC USD Fund IV at US$550 million.